IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.

Status unconfirmed

Conditions studied: SARS-CoV 2

In brief

The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.

Key facts

Study ID

NCT04402814

Run by

Fadi Haddad, M.D.

People needed

90

Starts

2020-05-05

Expected to finish

2020-12-01

Last updated by the study team

2020-07-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Received confirmed COVID-19 positive or negative test from Sharp HealthCare's standard method of testing.
• Age >/=18 years old.
• Access to a phone in the hospital room or an electronic device that is capable of receiving phone calls and/or video calls and/or e-mail.
• Able to read/write/speak English or Spanish fluently.
• Subjects must have the ability to understand the requirements of the study, provide informed consent, and provide authorization of use and disclosure of personal health information.
• Hospitalized at the time of consent or recently discharged with leftover blood stored at hospital laboratory

You may not qualify if…

• Impaired cognitive or decision-making capacity (based on the clinical judgment of the PI or designee)

Where it is running

• Fadi A. Haddad MD Inc. — La Mesa, California, United States (enrolling)
• Sharp Grossmont Hospital — La Mesa, California, United States (enrolling)
• Sharp Memorial Hosptial — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.